Myocardial Energetics Across Cardiovascular Disease Spectrum Using 31P-MRS
Official title: Myocardial Energetic Phenotyping and Prognostic Value Across the Cardiac Disease Spectrum: A 31P Magnetic Resonance Spectroscopy Study
Run by Chinese Academy of Medical Sciences, Fuwai Hospital · NCT07912086 · Data updated 2026-11-12
Researchers are testing whether phosphorus-31 magnetic resonance spectroscopy (31P-MRS) can map heart energy metabolism across healthy people and patients with various heart conditions.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Chinese Academy of Medical Sciences, Fuwai Hospital Academic / other |
| Locations | 1 site (Beijing) |
| Status | Recruiting |
| Started | August 1, 2025 |
| Main results expected | September 1, 2030 |
| Study ends | September 1, 2035 |
| Registry record updated | November 3, 2026 |
| Trial ID | NCT07912086 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 years and older, including healthy volunteers or patients with non-ischemic or ischemic cardiomyopathy, hypertensive or valvular heart disease, inflammatory or inherited metabolic cardiomyopathies, who can undergo CMR.
✕Probably not a fit
Patients unable to undergo CMR or without specific cardiomyopathy or heart failure phenotypes may receive limited or no direct benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study will enroll up to 1,000 participants, including healthy volunteers and patients with heart failure and a range of cardiomyopathies, to characterize myocardial energetic phenotypes. By combining 31P-MRS with multiparametric cardiac MRI, the study aims to define metabolic signatures that relate to structural changes and clinical biomarkers. The primary outcome is the myocardial PCr/ATP ratio, an in vivo marker of energetic impairment, with secondary exploration of relationships to remodeling and function. The trial is centered at the Chinese Academy of Medical Sciences and Fuwai Hospital in Beijing, led by a national sponsor.
Why it matters
Potential benefit: If successful, the study could identify metabolic markers that help classify cardiomyopathies and guide prognosis and individualized management.
How similar studies have gone: Previous pulse of work using 31P-MRS has shown feasibility in characterizing myocardial energetics, but this large, diverse cohort study is relatively novel in broad-spectrum phenotyping.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age \>= 18 years * Healthy volunteers, OR * Clinical diagnosis of cardiac disease, including non-ischemic cardiomyopathy (hypertrophic, amyloid, or inflammatory), ischemic cardiomyopathy, hypertensive heart disease, or valvular heart disease, OR * Inherited metabolic cardiomyopathies * Able to undergo CMR examination and provide written informed consent Exclusion Criteria: \* Any contraindication to CMR examination
Where it's running
-
Chinese Academy of Medical Sciences and Peking Union Medical College, Fuwai Hospital
Beijing, China Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
RHYthm and Myocardial Function Relationship in Heart Disease
This study tests how heart rhythm patterns relate to heart muscle function in adults with arrhythmias or cardiomyopathy.
-
Using retinal photographs to assess cardiovascular disease risk in heart failure patients
This study is testing if looking at retinal photographs can help predict the risk of heart problems in people who have recently been diagnosed with heart failure.
-
Using Apple Watch data to predict heart failure outcomes
This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.
-
Study of heart conditions using advanced imaging techniques
This study is trying to find out what causes different heart conditions in Hispanic and African American people in the Bronx by using advanced imaging techniques.
-
Biobank of stem cells and biomarkers for cardiovascular disease
This study is creating a bank of stem cells and blood samples from people with heart disease to help researchers learn more about the condition and find better treatments.
-
Colchicine treatment for chronic inflammatory cardiomyopathy
This study tests if colchicine can help people with chronic inflammatory cardiomyopathy who have heart issues feel better by reducing inflammation in their hearts.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.